Kirsch Speaks with Kilmeade about Vaccine Injuries

by Sharon Rondeau

(Aug. 11, 2022) — At approximately 8:40 PM EDT Wednesday, Silicon Valley entrepreneur Steve Kirsch was a guest on the “Tucker Carlson Tonight” show with guest host Brian Kilmeade, a rescheduling of a segment expected to occur Monday evening but preempted as a result of the FBI presence at former President Donald Trump’s Florida Mar-a-Lago residence.

Kilmeade introduced the segment with, “A lifelong Democrat megadonor who has given millions to the party says he’s just about seen enough. What pushed him to finally jump ship?” before the show broke to advertising.

Kirsch was an early Silicon Valley tech entrepreneur and philanthropist who at the outset of the pandemic decided to retire and sponsor COVID-19 treatment research. He founded the COVID-19 Early Treatment Fund and later, the Vaccine Safety Research Foundation (VSRF) focused on bringing to light the plight of those injured from COVID-19 injections which U.S. public health agencies say are “safe and effective” but which the government’s own data show serious “safety signals” and unexplained deaths, according to many physicians and scientists.

Each Thursday evening, VSRF holds a free webinar featuring a variety of guests from medical, legal and ethical perspectives working to raise awareness of the impact the vaccines have had on Americans, up to and including death.

Since Kirsch began to speak out about the risks of COVID-19 vaccines, Wikipedia has altered his page to read, “Kirsch has been both a philanthropic supporter of medical research, and a promoter of misinformation about COVID-19 vaccines.” He has been banned from LinkedIn, Twitter and other social media and primarily uses his broadcasts and Substack blog to update his followers on new research, which is supported by a team of medical doctors and scientists.

A press release dated August 8, 2022 on Kirsch’s Substack is titled, “Why is a $20M Dem Donor About to Jump Ship?” and subtitled, “They don’t share any of my core values at all anymore.”

The press release begins:

WASHINGTON, DC – In 2003, former U.S. Senator and Secretary of State, Hillary Clinton, presented Steve Kirsch, along with his wife Michele, with the National Caring Award from the Caring Institute in Washington DC. The Caring Awards promote and honor acts of caring and humanitarian service around the country and internationally.

Kirsch, a Silicon Valley entrepreneur, an MIT graduate, and philanthropist, has founded seven highly successful companies.

At the beginning of COVID-19, Steve funded the first studies on the repurposed drug Fluvoxamine as an early treatment for the virus and the successful results were featured on 60 Minutes in April of 2021. He also has been profiled in Forbes Magazine and pens one of the most read Substacks on Twitter.

Kirsch is a cancer survivor, having been diagnosed with Waldenstrom’s Macroglobulinemia, a rare blood cancer, in 2007. He turned to world-renowned scientists to develop a treatment that has proved effective beyond his projected life expectancy. The story was the feature of his profile in Forbes magazine.

Page 2 states, in part:

When the COVID-19 pandemic stopped the world in its tracks, Kirsch knew he had to resort to research and science once again to find a solution. As hundreds of thousands were suffering and dying from COVID, Kirsch was funding studies to research effective cures using Fluvoxamine and other common repurposed drugs. Yet, he was perplexed. Despite the success of the initial and follow up Fluvoxamine studies Fluvoxamine was still not recognized and promoted by the NIH or CDC as an early treatment protocol. This
readily available medication to prevent hospitalizations and save lives was ignored and suppressed like other early treatment solutions. Kirsch began to ask questions.

The rollout of the Covid-19 vaccines brought on even more questions.

“I used to believe that the FDA, NIH, and CDC were honest organizations,” says Kirsch. “I trusted them. I’m doubly-vaxed with Moderna as of March 29, 2021. A month later, I started hearing stories from my friends who reported relatives who died or they themselves became permanently disabled. So, I looked into it and the more I looked, the more appalled I became.”

Following the break, Kilmeade introduced Kirsch with, “For many years, Steve Kirsch was a Democratic-Party megadonor. He says he’s given more than $20 million to help elect Democrats, and now he might just be jumping ship. Steve Kirsch is an entrepreneur, self-made success story and joins us now to explain his reasoning. Steve, when did the Democratic Party start going south with you?”

Kirsch immediately turned the conversation to the reported dangers of COVID-19 vaccines, replying, “Well, when they violated my trust, Brian. They told – the agencies, the FDA, CDC, and the NIH said that these vaccines were safe and effective, and when I started seeing my friends die and be injured and started looking at the data, there was no question that this vaccine is the most dangerous vaccine ever created by man. It is a thousand times more deadly than the smallpox vaccine, and that’s too unsafe for people to use, and I could not get even a single minute in front of any Democratic congressman. The best I got was that Ro Khanna gave me to a staff member who took two months to get back to me, and when I asked if she had read what I had sent her, she said, ‘No, it disagreed with the CDC, so it’s not right and so I didn’t really read it.'”

“What did you find was effective, and what was the reaction when you put it out there?” Kilmeade responded.

“What I found was that hundreds of thousands of Americans have been killed by this vaccine, and millions have been injured…” Kirsch replied.

The full interview can be found here beginning at 28:03 or here.

A copious writer, Kirsch recapped his appearance later Wednesday night with a post tilted, “Mainstream media claims my statements today on Fox News were false. Wanna bet?” and subtitled, “If the fact checkers are so sure that the statements I made were false, there is a million dollars that is waiting for them to claim. Will any of them take it? No way.”

Those statements echoed multiple longstanding offers Kirsch has made to the CDC, FDA and NIH to challenge his assertions in an open forum about the shots’ efficacy and safety.

To detractor Media Matters’ post, which bears a general byline and consists solely of a title, subtitle, video of the interview and three paragraphs of transcript claiming Kirsch “lied,” Kirsch wrote,

Once you are ready to defend your claims with data, let’s do it on a livestream. I’d like to invite my hundreds of thousands of followers.

I’ve spent an average of over 10 hours every day for more than a year looking at the data. Presumably, you have someone on staff who is equally familiar with the data.

If you are not prepared to defend your statements, then you should do the right thing and you should retract your story.

Or, if you like, I’m offering you a chance to win $1M by challenging me in front of an impartial panel of mutually selected judges. If you’re so confident you are right, why not accept my bet?…”

Regular host Tucker Carlson has also begun to feature segments regarding the questionable safety and efficacy of the vaccine products which were rushed to market in 2020 under former President Trump’s “Operation Warp Speed” with the purpose of swiftly ending the pandemic.

In a recent appearance with Fox News’s Neil Cavuto, former White House COVID Coordinator Dr. Deborah Birx admitted that at the time, “I knew these vaccines were not going to protect against infection, and I think we overplayed the vaccines and it made people then worried that it’s not going to protect against severe disease and hospitalization. It will, but let’s be very clear: 50% of the people who died from the Omicron were older, vaccinated.”

Birx then said “the key” to “save your lives right now” is taking the Pfizer anti-viral Paxlovid, which has been noted to have a “rebound” effect in those already “vaccinated,” including in NAIAD Director Dr. Anthony Fauci and White House occupant Joe Biden.